- Name: Dong Pei
- Title: Attending doctor
- Email: dongpei@sysucc.org.cn
- Phone:
Profile
Surgical treatment of urologic oncology and anti-prostate cancer drug research. The mechanism of prostate cancer progression. In recent years, we investigated Prohibitin plays an important role in the progression of castration-resistant prostate cancer (CRPC) through regulating SREBP and E2F signal pathways.We are now studying the role of prohibitin regulate intratumoral androgen synthesis leading to CRPC progression. The target of this study is to discover the mechanism of Prohibitin promoted progression of CRPC and provide new target for CRPC therapy.
Interests
Education
9/2005 –7/2009: M.D in surgery, XiangYa Medical College,Central South University
Research area: Urological tumor research
9/2002-6/2005: M.M in surgery, Hunan University of Chinese Medicine
Research area: Application of Chinese medicine in tumor therapy
9/1996-6/2001:B.S in medicine, NanHua University
Publications
Updated by International Office, Sun Yat-sen University Cancer Center